Lifecore Biomedical (LCBM) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Lifecore Biomedical (LCBM)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mike who wrote (13)	6/12/1999 1:58:00 AM
From: PaperChase	Read Replies (2) of 43

Until management comes clean about why inventory is at an absolutely absurd level, then I am avoiding this one. I've heard the stories about how LCBM is building inventory for expected future increases in demand from the BL deal (when approved) and for when they receive FDA approval of their PMA on Intergel. However, I've been hearing these lines now for well over a year and I find it hard to believe them at this point. LCBM management is wasting precious working capital by maintaining such a high inventory level all the while HA sales are flat or decreasing. Also, the street.com did a write-up on this stock on May 6th. Can anybody give us the skinny about what the article said? BTW, the share price of Closure (CLSR) is falling and a lot of investors are blaming Ethicon for CLSR's slow ramp-up in sales. I don't know what to think about this. I know that Focal (FOCL) hasn't had much success with Ethicon as their exclusive distributor in Europe. And I believe Ethicon is distributing Intergel in Europe for LCBM and these sales have gone nowhere. Just some food for thought.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next